Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash from Financing Activities (2016 - 2025)

cbdMD's Cash from Financing Activities history spans 10 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities changed N/A year-over-year to $2.1 million; the TTM value through Dec 2025 reached $3.5 million, up 173.01%, while the annual FY2025 figure was $1.4 million, 11.39% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.1 million at cbdMD, up from $1.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $13.8 million in Q3 2021 and bottomed at -$1.1 million in Q4 2022.
  • The 5-year median for Cash from Financing Activities is -$619751.0 (2021), against an average of $752267.8.
  • The largest annual shift saw Cash from Financing Activities tumbled 142.35% in 2021 before it surged 144523500.0% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.0 million in 2021, then fell by 10.92% to -$1.1 million in 2022, then soared by 99.78% to -$2501.0 in 2023, then surged by 100.04% to $1.0 in 2024, then surged by 210395600.0% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Cash from Financing Activities are $2.1 million (Q4 2025), $1.4 million (Q3 2025), and $1.0 (Q3 2024).